Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-10

Clinical Trial Update: Study to Assess Safety and Efficacy of sc Pasireotide in Patients With Dumping Syndrome [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety and efficacy of subcutaneous pasireotide in patients with postoperative dumping syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pasireotide (pasireotide)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Postoperative Dumping Syndrome | Phase 2 | Status: COMPLETED